The hepatic overexpression of FGF21 in liver-specific SIRT1 knockout mice increases the expression of genes involved in fatty acid oxidation, thereby decreasing fasting-induced steatosis, reducing obesity, increasing energy expenditure, and promoting the browning of white adipose tissue. The gene discussed is FGF21; the disease is steatosis.